Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash Flows from Operating Activities:
Net Loss	$ (2,278,177)	$ (4,148,088)
Adjustments to reconcile net loss to net cash used in Operating activities:
Depreciation and amortization	56,446	51,663
Amortization of discounts and deferred financing costs	141,869	854,149
Bad debt expense	20,273	24,917
Inventory obsolescence	83,420	244,540
Gain on settlement of liabilities	0	(192,142)
Series D preferred stock issued for services	311,536	925,787
Common stock issued for services	222,550	275,927
Common stock issued for loan extensions	0	16,612
Warrant expense	0	287,599
True-up related to warrants issued in 2011	0	489,614
Recognition of deferred compensation related to vested options	0	86,350
Gain on fair market value of derivative liabilities	(78,145)	(365,496)
Convertible debt issued for settlements	0	90,000
Changes in assets and liabilities:
(Increase) decrease in accounts receivable	(76,985)	(42,499)
(Increase) decrease in inventory	(178,448)	(97,831)
(Increase) decrease in employee advances	3,620	8,212
(Increase) decrease in accrued interest receivable	0	0
(Increase) decrease in prepaids and other assets	69,908	(64,897)
Increase (decrease) in allowance for uncollectible interest	0	0
Increase (decrease) in accrued royalties and dividends	(50,714)	(428,238)
Increase (decrease) in accounts payable	18,100	(67,965)
Increase (decrease) in accrued liabilities	(260)	(21,838)
Increase (decrease) in accrued interest payable	48,322	251,643
Net cash flows used in operating activities	(1,686,685)	(1,821,981)
Cash flows from investing activities:
Payments made on capital lease obligation	(375)	0
Purchase of property and equipment	(8,072)	(29,892)
Net cash flows used in investing activities	(8,447)	(29,892)
Cash flows from financing activities:
Borrowings on debt	0	290,244
Payments on debt	(23,600)	(662,169)
Borrowings on convertible debt, net of original issue discounts	0	1,817,400
Payments on convertible debt	(44,900)	(331,500)
Cash paid for debt issuance costs	0	(9,200)
Cash proceeds from sale of series C preferred stock	2,252,510	740,030
Proceeds from exercise of warrants	0	5,760
Cash paid for return of Series D preferred stock	(9,990)	0
Net cash flows provided by financing activities	2,174,020	1,850,565
Net increase (decrease) in cash	478,888	(1,308)
Cash and cash equivalents, beginning of period	44,553	45,861
Cash and cash equivalents, end of period	523,441	44,553
Cash paid during the period for:
Interest	103,705	130,147
Income Taxes	0	0
Supplemental non-cash investing and financing activities:
Common stock issued for conversion of debt and interest	93,728	406,645
Common stock issued for conversion of series D preferred stock	40,000	0
Series C preferred stock issued for conversion of related party debt and interest	0	348,600
Series C preferred stock issued for conversion of debt and interest	0	1,587,600
Resolution of derivative liabilities due to warrant exercise	0	48,630
Resolution of warrant derivative liabilities due to removal of convertible debt	918,580	0
Resolution of derivative liabilities due to debt conversions	132,417	1,311,702
Warrants reclassed to derivative liabilities	0	812,705
Debt discounts due to derivative liabilities	90,000	617,399
Debt discounts due to warrants issued with debt	0	51,643
Debt discounts due to beneficial conversion feature	0	25,000
Reversal of deferred compensation due to forfeiture of nonvested options	0	184,800
Write-off of deferred compensation	0	38,300
Reclass of related party debt to unrelated party debt	115,620	0
Reclass of related party interest payable to unrelated party interest payable	47,061	0
Capital lease obligation	$ 13,512	$ 0